Rate this Article: Structure-Based Drug Repurposing Through Molecular Docking and ADMET Profiling of FDA-Approved Drugs Targeting SARS-CoV-2 Main Protease (Mpro)

Rating (1-10):

1

Comments (SR26201102349):

Please enter 100–200 characters. 0/200 characters

Full Name: Email Address (Important: You will receive Rating Verification Link on this Email Address):

Leave this field empty

Back to Article